 |
Articles: General Pharma |
Prior Articles
European Approval for UCB's Cimzia
PharmExec, 06/29/09
Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel
Current Medical Research and Opinion, 06/29/09 Regulatory aspects of biosimilars in Europe
Trends in Biotechnology, 06/29/09 Mitigating release of the potent greenhouse gas N2O from the nitrogen cycle - could enzymic regulation hold the key
Trends in Biotechnology, 06/29/09 Once-yearly Aclasta approved in EU to treat osteoporosis caused by steroid treatment in men and postmenopausal women
Novartis, 06/29/09
Free full text
Seretide: Irish patent litigation update
GlaxoSmithKline, 06/29/09
Free full text
AVI BioPharma Joining Russell 3000 Index
AVI BioPharma, 06/29/09
Free full text
FDA Tells Drug and Device Makers to Give Balanced Picture of Risks in Ads, Labels
JAMA, 06/29/09 Erlotinib Warning
JAMA, 06/29/09 New Developments for "CHUGAI ONCOLOGY": Establishment of "Cancer Information Guide," a Website for Patients
Chugai Pharmaceutical Co., 06/29/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/29/09
Free full text
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
Boston Scientific, 06/26/09
Free full text
MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination
Avigen, 06/26/09
Free full text
Zila Enters into Merger Agreement with Tolmar
Zila, 06/26/09
Free full text
BioMimetic Therapeutics, Inc. Announces Completion of Rights Offering and Sale of Shares in Standby Purchase
BioMimetic Therapeutics, 06/26/09 CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering
CEL-SCI, 06/26/09 King Pharmaceuticals Showcases Data from Pain Pipeline of Medicines Designed To Deter Common Methods of Non-Therapeutic Use
King Pharmaceuticals, 06/26/09
Free full text
Lundbeck receives FDA Complete Response Letter on Serdolect for the treatment of schizophrenia
Lundbeck, 06/26/09
Free full text
CEL-SCI Files Patent Application to Support Company's Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses
CEL-SCI, 06/26/09 Genzyme Reports Progress Related to Allston Plant
Genzyme, 06/26/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
